3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostate Adenocarcinoma
2
Neoplasm Metastasis
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Primary Dysautonomias
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Kidney Diseases
1
Hypertension
1
Glioma
1
Glioblastoma
1
Carcinoma, Renal Cell
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
bicalutamide
×
1 year
×
Clear all
No trials found.